Eli Lilly Stock Slips as Hyped-Up Obesity Drug Sales…
Text dimension Eli Lilly reported fourth-quarter earnings nicely forward of analysts’ estimates.…
Text dimension Eli Lilly reported fourth-quarter earnings nicely forward of analysts’ estimates.…
Text size Albert Bourla, chief executive officer of Pfizer. Hollie Adams/Bloomberg Pfizer…
Pfizer Inc. PFE -0.55% expects revenue to drop by as much as a third in 2023 as demand for Covid-19…
Text size Analysts expect Pfizer’s Covid-19 vaccine sales to drop to $14.2 billion in 2023 from an…
A federal appeals court rejected Johnson & Johnson ‘s plan to use a legal strategy to push…
It will be another major week of fourth-quarter earnings, with about 100 S&P 500 companies …
Talk about a comeback. As China abandons policies that stifled economic growth for three years, its…
Talk a couple of comeback. As China abandons insurance policies that stifled financial development…
Pfizer’s PFE, -0.92% early-stage pipeline, although promising, continues to be too untimely to make…
Text dimension Abbott shares had been falling about 1.8% early Wednesday. (Photo by Tim Boyle/Getty…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.